Suchergebnisse - (Subject:"2019-nCoV")

PubPharm (2.091)

1

Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021

enthalten in: Vaccine | 2024

von Archer, H. | McCoy, S. | Sears, D. | +4

2

COVID-19 Australia : Epidemiology Report 85: Reporting period ending 10 March 2024

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Team

3

COVID-19 Australia : Epidemiology Report 84: Reporting period ending 11 February 2024

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Team

4

mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

enthalten in: Journal of autoimmunity | 2024

von van den Dijssel, J. | Duurland, M. | Konijn, V. | +77

5

Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults : a Nordic cohort study

enthalten in: European heart journal | 2024

von Hviid, A. | Nieminen, T. | Pihlström, N. | +9

6

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients : Single center experience

enthalten in: Medicina clinica | 2024

von Huguet, M. | Boigues, M. | Sorigué, M. | +20

7

COVID-19 Australia : Epidemiology Report 83: Reporting period ending 14 January 2024

enthalten in: Communicable diseases intelligence (2018) | 2024

von Viral Respiratory Diseases Epidemiology and Surveillance Team

8

COVID-19 vaccines and adverse events of special interest : A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

enthalten in: Vaccine | 2024

von Faksova, K. | Walsh, D. | Jiang, Y. | +32

9

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination

enthalten in: JAMA network open | 2024

von Gorochov, G. | Ropers, J. | Launay, O. | +32

10

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults : A randomized trial

enthalten in: Human vaccines & immunotherapeutics | 2024

von Naficy, A. | Kuxhausen, A. | Seifert, H. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[210]